mAb therapy reduces risk of hospitalization and death against Alpha, Delta, and Omicron variants
Researchers assess the efficacy of monoclonal antibodies in treating COVID-19 caused by different viral variants.
Nilsbwoy Shutterstock University Of Pittsburgh Medical Center Internal Medicine Evolving Real World Effectiveness Monoclonal Antibodies Image Credit
Source: news-medical.net